Literature DB >> 31857390

Effects of omega-O-acylceramide structures and concentrations in healthy and diseased skin barrier lipid membrane models.

Lukáš Opálka1, Andrej Kováčik1, Petra Pullmannová1, Jaroslav Maixner2, Kateřina Vávrová3.   

Abstract

Ceramides (Cers) with ultralong (∼32-carbon) chains and ω-esterified linoleic acid, composing a subclass called omega-O-acylceramides (acylCers), are indispensable components of the skin barrier. Normal barriers typically contain acylCer concentrations of ∼10 mol%; diminished concentrations, along with altered or missing long periodicity lamellar phase (LPP), and increased permeability accompany an array of skin disorders, including atopic dermatitis, psoriasis, and ichthyoses. We developed model membranes to investigate the effects of the acylCer structure and concentration on skin lipid organization and permeability. The model membrane systems contained six to nine Cer subclasses as well as fatty acids, cholesterol, and cholesterol sulfate; acylCer content-namely, acylCers containing sphingosine (Cer EOS), dihydrosphingosine (Cer EOdS), and phytosphingosine (Cer EOP) ranged from zero to 30 mol%. Systems with normal physiologic concentrations of acylCer mixture mimicked the permeability and nanostructure of human skin lipids (with regard to LPP, chain order, and lateral packing). The models also showed that the sphingoid base in acylCer significantly affects the membrane architecture and permeability and that Cer EOP, notably, is a weaker barrier component than Cer EOS and Cer EOdS. Membranes with diminished or missing acylCers displayed some of the hallmarks of diseased skin lipid barriers (i.e., lack of LPP, less ordered lipids, less orthorhombic chain packing, and increased permeability). These results could inform the rational design of new and improved strategies for the barrier-targeted treatment of skin diseases.
Copyright © 2020 Opálka et al.

Entities:  

Keywords:  acylceramide; ceramides; disease models; epidermis; extracellular matrix; membrane nanostructure; membranes/model; permeability; sphingolipids

Year:  2019        PMID: 31857390      PMCID: PMC6997605          DOI: 10.1194/jlr.RA119000420

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  65 in total

1.  Modeling skin permeability to hydrophilic and hydrophobic solutes based on four permeation pathways.

Authors:  Samir Mitragotri
Journal:  J Control Release       Date:  2003-01-09       Impact factor: 9.776

2.  Changes in the ceramide profile of atopic dermatitis patients.

Authors:  Junko Ishikawa; Hirofumi Narita; Naoki Kondo; Mitsuyuki Hotta; Yutaka Takagi; Yoshinori Masukawa; Takashi Kitahara; Yoshinori Takema; Satomi Koyano; Soji Yamazaki; Atsushi Hatamochi
Journal:  J Invest Dermatol       Date:  2010-06-24       Impact factor: 8.551

3.  Two ceramide subfractions detectable in Cer(AS) position by HPTLC in skin surface lipids of non-lesional skin of atopic eczema.

Authors:  O Bleck; D Abeck; J Ring; U Hoppe; J P Vietzke; R Wolber; O Brandt; V Schreiner
Journal:  J Invest Dermatol       Date:  1999-12       Impact factor: 8.551

4.  Probing the role of ceramide hydroxylation in skin barrier lipid models by 2H solid-state NMR spectroscopy and X-ray powder diffraction.

Authors:  Andrej Kováčik; Alexander Vogel; Juliane Adler; Petra Pullmannová; Kateřina Vávrová; Daniel Huster
Journal:  Biochim Biophys Acta Biomembr       Date:  2018-02-22       Impact factor: 3.747

5.  Phase behavior of isolated skin lipids.

Authors:  J A Bouwstra; G S Gooris; K Cheng; A Weerheim; W Bras; M Ponec
Journal:  J Lipid Res       Date:  1996-05       Impact factor: 5.922

6.  Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin?

Authors:  G Imokawa; A Abe; K Jin; Y Higaki; M Kawashima; A Hidano
Journal:  J Invest Dermatol       Date:  1991-04       Impact factor: 8.551

7.  Ceramide and cholesterol composition of the skin of patients with atopic dermatitis.

Authors:  A Di Nardo; P Wertz; A Giannetti; S Seidenari
Journal:  Acta Derm Venereol       Date:  1998-01       Impact factor: 4.437

8.  Stratum corneum lipids, skin barrier function and filaggrin mutations in patients with atopic eczema.

Authors:  J M Jungersted; H Scheer; M Mempel; H Baurecht; L Cifuentes; J K Høgh; L I Hellgren; G B E Jemec; T Agner; S Weidinger
Journal:  Allergy       Date:  2010-02-04       Impact factor: 13.146

9.  Deficiency of epidermal protein-bound omega-hydroxyceramides in atopic dermatitis.

Authors:  Oliver Macheleidt; Hans Wilhelm Kaiser; Konrad Sandhoff
Journal:  J Invest Dermatol       Date:  2002-07       Impact factor: 8.551

10.  Skin barrier defect in atopic dermatitis: increased permeability of the stratum corneum using dimethyl sulfoxide and theophylline.

Authors:  T Yoshiike; Y Aikawa; J Sindhvananda; H Suto; K Nishimura; T Kawamoto; H Ogawa
Journal:  J Dermatol Sci       Date:  1993-04       Impact factor: 4.563

View more
  7 in total

1.  Exogenous Ceramide Serves as a Precursor to Endogenous Ceramide Synthesis and as a Modulator of Keratinocyte Differentiation.

Authors:  Kyong-Oh Shin; Hisashi Mihara; Kenya Ishida; Yoshikazu Uchida; Kyungho Park
Journal:  Cells       Date:  2022-05-25       Impact factor: 7.666

2.  ω-O-Acylceramides but not ω-hydroxy ceramides are required for healthy lamellar phase architecture of skin barrier lipids.

Authors:  Lukáš Opálka; Jason M Meyer; Veronika Ondrejčeková; Linda Svatošová; Franz P W Radner; Kateřina Vávrová
Journal:  J Lipid Res       Date:  2022-05-12       Impact factor: 6.676

Review 3.  Clinical and biochemical footprints of inherited metabolic diseases. VI. Metabolic dermatoses.

Authors:  Carlos R Ferreira; Diego Martinelli; Nenad Blau
Journal:  Mol Genet Metab       Date:  2021-07-21       Impact factor: 4.204

4.  Changes in levels of omega-O-acylceramides and related processing enzymes of sun-exposed and sun-protected facial stratum corneum in differently pigmented ethnic groups.

Authors:  Anthony V Rawlings; Rotraut Schoop; Christian Klose; Jean-Marc Monneuse; Beverley Summers; Rainer Voegeli
Journal:  Int J Cosmet Sci       Date:  2022-03-13       Impact factor: 2.416

Review 5.  PNPLA1-Mediated Acylceramide Biosynthesis and Autosomal Recessive Congenital Ichthyosis.

Authors:  Fansi Zeng; Wenzhen Qin; Feifei Huang; Pingan Chang
Journal:  Metabolites       Date:  2022-07-26

Review 6.  Current knowledge of the implication of lipid mediators in psoriasis.

Authors:  Mélissa Simard; Sophie Morin; Zainab Ridha; Roxane Pouliot
Journal:  Front Immunol       Date:  2022-08-26       Impact factor: 8.786

Review 7.  Ceramides in Skin Health and Disease: An Update.

Authors:  Yoshikazu Uchida; Kyungho Park
Journal:  Am J Clin Dermatol       Date:  2021-07-20       Impact factor: 7.403

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.